Safety of ustekinumab in inflammatory bowel diseases (IBD): pooled safety analysis through 5 years in Crohn's disease (CD) and 2 years in ulcerative colitis (UC)

被引：0
|
作者：
Ghosh, Subrata [1 ]
Ott, Elyssa [2 ]
Gasink, Christopher [2 ]
Miao, Ye [3 ]
Colombel, Jean-Frederic [4 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷
关键词：
ustekinumab; IBD; safety; MACE;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP-0097
引用
收藏
页码：107 / 107
页数：1
相关论文
共 50 条
  • [1] Safety of Ustekinumab in Inflammatory Bowel Disease: Pooled Safety Analysis Through 5 Years in Crohn's Disease and 4 Years in Ulcerative Colitis
    Ghosh, Subrata
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Godwin, Bridget
    Marano, Colleen
    Miao, Ye
    Ma, Tony
    Loftus, Edward, V
    Sandborn, William J.
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 (07): : 1091 - 1101
  • [2] Safety of ustekinumab in inflammatory bowel diseases (IBD): pooled safety analysis through 5 years in Crohn
    Sandborn, William J.
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Lynch, John
    Marano, Colleen
    Miao, Ye
    Tikhonov, Ilia
    Danese, Silvio
    Sands, Bruce E.
    Ghosh, Subrata
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 108 - 108
  • [3] SAFETY OF USTEKINUMAB IN IBD: POOLED SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 2 YEARS IN UC
    Sandborn, William J.
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Lynch, John P.
    Marano, Colleen W.
    Miao, Ye
    Tikhonov, Ilia
    Danese, Silvio
    Sands, Bruce E.
    Ghosh, Subrata
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S35 - S36
  • [4] SAFETY OF USTEKINUMAB IN IBD: FINAL POOLED LONG-TERM SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 4 YEARS IN UC
    Sands, Bruce E.
    Feagan, Brian G.
    Ott, Elyssa
    Gasink, Christopher
    Marano, Colleen W.
    Miao, Ye
    Sandborn, William J.
    Danese, Silvio
    Abreu, Maria T.
    Ghosh, Subrata
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S889 - S889
  • [5] Safety of ustekinumab in IBD: Final pooled long-term safety analysis through 5 years in CD and 4 years in UC
    Ghosh, S.
    Feagan, B.
    Ott, E.
    Gasink, C.
    Marano, C.
    Miao, Y.
    Sandborn, W.
    Danese, S.
    Abreu, M.
    Sands, B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2023, 17 : I55 - I55
  • [6] Safety of Ustekinumab in Older IBD Patients (≥60 Years): Pooled Safety Analysis Through 5 Years in CD and 2 Years in UC and All Approved Indications
    Abreu, Maria T.
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Marano, Colleen
    Lynch, John
    Charabaty, Aline
    Ghosh, Subrata
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S415 - S415
  • [7] LONG-TERM SAFETY OF USTEKINUMAB IN IBD PATIENTS WITH A HISTORY OF BIOLOGIC FAILURE: POOLED SAFELY ANALYSIS THROUGH 5 YEARS IN CROHN'S DISEASE AND 2 YEARS IN ULCERATIVE COLITIS
    Loftus, Edward V.
    Lee, Scott D.
    Panaccione, Remo
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Marano, Colleen W.
    Ghosh, Subrata
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S960 - S960
  • [8] Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn's Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years
    Long, Millie D.
    Danese, Silvio
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Baker, Thomas
    Tikhonov, Ilia
    Rahman, Proton
    Strober, Bruce
    Loftus, Edward V.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S440 - S440
  • [9] SAFETY OF USTEKINUMAB IN IBD: A COMPREHENSIVE ANALYSIS OF MAJOR CARDIOVASCULAR EVENTS (MACE) THROUGH 5 YEARS IN CD AND 2 YEARS IN UC
    Ghosh, Subrata
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Colombel, Jean Frederic
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S37 - S37
  • [10] Safety of Ustekinumab in Inflammatory Bowel Diseases: Integrated Safety Analysis of Results From Phase 2 and 3 Studies in Crohn's Disease and Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    O'Brien, Christopher D.
    Ott, Elyssa
    Marano, Colleen
    Zhou, Yiying
    Volger, Sheri
    Tikhonov, Ilia
    Gasink, Christopher
    Danese, Silvio
    Sands, Bruce E.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S408 - S409
12345